nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Framycetin—CXCR4—acquired immunodeficiency syndrome	0.0314	1	CrCbGaD
Tobramycin—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000883	0.000912	CcSEcCtD
Tobramycin—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000881	0.00091	CcSEcCtD
Tobramycin—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000878	0.000906	CcSEcCtD
Tobramycin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000875	0.000903	CcSEcCtD
Tobramycin—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000874	0.000902	CcSEcCtD
Tobramycin—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000874	0.000902	CcSEcCtD
Tobramycin—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000872	0.0009	CcSEcCtD
Tobramycin—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000866	0.000895	CcSEcCtD
Tobramycin—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000864	0.000892	CcSEcCtD
Tobramycin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000861	0.000889	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000861	0.000888	CcSEcCtD
Tobramycin—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000859	0.000887	CcSEcCtD
Tobramycin—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000858	0.000885	CcSEcCtD
Tobramycin—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000856	0.000884	CcSEcCtD
Tobramycin—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000854	0.000881	CcSEcCtD
Tobramycin—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000853	0.000881	CcSEcCtD
Tobramycin—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000852	0.00088	CcSEcCtD
Tobramycin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000852	0.00088	CcSEcCtD
Tobramycin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000851	0.000878	CcSEcCtD
Tobramycin—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00085	0.000877	CcSEcCtD
Tobramycin—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000848	0.000875	CcSEcCtD
Tobramycin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000847	0.000875	CcSEcCtD
Tobramycin—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000845	0.000872	CcSEcCtD
Tobramycin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000845	0.000872	CcSEcCtD
Tobramycin—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000845	0.000872	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000845	0.000872	CcSEcCtD
Tobramycin—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000843	0.000871	CcSEcCtD
Tobramycin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00084	0.000868	CcSEcCtD
Tobramycin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00084	0.000867	CcSEcCtD
Tobramycin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000835	0.000862	CcSEcCtD
Tobramycin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000833	0.00086	CcSEcCtD
Tobramycin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000832	0.000859	CcSEcCtD
Tobramycin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000832	0.000859	CcSEcCtD
Tobramycin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000832	0.000859	CcSEcCtD
Tobramycin—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000829	0.000855	CcSEcCtD
Tobramycin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000827	0.000854	CcSEcCtD
Tobramycin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000826	0.000853	CcSEcCtD
Tobramycin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000825	0.000852	CcSEcCtD
Tobramycin—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000824	0.000851	CcSEcCtD
Tobramycin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000823	0.000849	CcSEcCtD
Tobramycin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000821	0.000848	CcSEcCtD
Tobramycin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000821	0.000848	CcSEcCtD
Tobramycin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00082	0.000847	CcSEcCtD
Tobramycin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000818	0.000845	CcSEcCtD
Tobramycin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000815	0.000841	CcSEcCtD
Tobramycin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000814	0.00084	CcSEcCtD
Tobramycin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000814	0.00084	CcSEcCtD
Tobramycin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000813	0.000839	CcSEcCtD
Tobramycin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000811	0.000838	CcSEcCtD
Tobramycin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000811	0.000837	CcSEcCtD
Tobramycin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000809	0.000835	CcSEcCtD
Tobramycin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000808	0.000835	CcSEcCtD
Tobramycin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000808	0.000835	CcSEcCtD
Tobramycin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000806	0.000832	CcSEcCtD
Tobramycin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000806	0.000832	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000803	0.000829	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.0008	0.000826	CcSEcCtD
Tobramycin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000799	0.000825	CcSEcCtD
Tobramycin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000799	0.000825	CcSEcCtD
Tobramycin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000799	0.000825	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000798	0.000824	CcSEcCtD
Tobramycin—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000797	0.000823	CcSEcCtD
Tobramycin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000797	0.000822	CcSEcCtD
Tobramycin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000793	0.000818	CcSEcCtD
Tobramycin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000792	0.000818	CcSEcCtD
Tobramycin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000788	0.000813	CcSEcCtD
Tobramycin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000788	0.000813	CcSEcCtD
Tobramycin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000787	0.000813	CcSEcCtD
Tobramycin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000786	0.000812	CcSEcCtD
Tobramycin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000786	0.000812	CcSEcCtD
Tobramycin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000785	0.00081	CcSEcCtD
Tobramycin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000785	0.00081	CcSEcCtD
Tobramycin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000783	0.000809	CcSEcCtD
Tobramycin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000781	0.000807	CcSEcCtD
Tobramycin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000781	0.000806	CcSEcCtD
Tobramycin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00078	0.000806	CcSEcCtD
Tobramycin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000778	0.000803	CcSEcCtD
Tobramycin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000778	0.000803	CcSEcCtD
Tobramycin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000773	0.000798	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000773	0.000798	CcSEcCtD
Tobramycin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000769	0.000794	CcSEcCtD
Tobramycin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000764	0.000789	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000763	0.000788	CcSEcCtD
Tobramycin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000761	0.000786	CcSEcCtD
Tobramycin—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000761	0.000785	CcSEcCtD
Tobramycin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000761	0.000785	CcSEcCtD
Tobramycin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00076	0.000785	CcSEcCtD
Tobramycin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000759	0.000783	CcSEcCtD
Tobramycin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000758	0.000783	CcSEcCtD
Tobramycin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000758	0.000783	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000756	0.000781	CcSEcCtD
Tobramycin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000755	0.00078	CcSEcCtD
Tobramycin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000753	0.000777	CcSEcCtD
Tobramycin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000752	0.000777	CcSEcCtD
Tobramycin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000752	0.000776	CcSEcCtD
Tobramycin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000749	0.000773	CcSEcCtD
Tobramycin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000749	0.000773	CcSEcCtD
Tobramycin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000748	0.000772	CcSEcCtD
Tobramycin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000747	0.000771	CcSEcCtD
Tobramycin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000747	0.000771	CcSEcCtD
Tobramycin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000744	0.000768	CcSEcCtD
Tobramycin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000742	0.000766	CcSEcCtD
Tobramycin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000742	0.000766	CcSEcCtD
Tobramycin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000739	0.000763	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000737	0.000761	CcSEcCtD
Tobramycin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000736	0.00076	CcSEcCtD
Tobramycin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000733	0.000757	CcSEcCtD
Tobramycin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000733	0.000757	CcSEcCtD
Tobramycin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000733	0.000757	CcSEcCtD
Tobramycin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000731	0.000755	CcSEcCtD
Tobramycin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000731	0.000755	CcSEcCtD
Tobramycin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00073	0.000754	CcSEcCtD
Tobramycin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000729	0.000753	CcSEcCtD
Tobramycin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000728	0.000752	CcSEcCtD
Tobramycin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000725	0.000749	CcSEcCtD
Tobramycin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000725	0.000748	CcSEcCtD
Tobramycin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000724	0.000748	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000723	0.000747	CcSEcCtD
Tobramycin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000723	0.000747	CcSEcCtD
Tobramycin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000722	0.000746	CcSEcCtD
Tobramycin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000722	0.000745	CcSEcCtD
Tobramycin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000721	0.000744	CcSEcCtD
Tobramycin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000718	0.000742	CcSEcCtD
Tobramycin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000718	0.000742	CcSEcCtD
Tobramycin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000717	0.000741	CcSEcCtD
Tobramycin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000717	0.00074	CcSEcCtD
Tobramycin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000716	0.000739	CcSEcCtD
Tobramycin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000715	0.000738	CcSEcCtD
Tobramycin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000712	0.000735	CcSEcCtD
Tobramycin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000712	0.000735	CcSEcCtD
Tobramycin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000712	0.000735	CcSEcCtD
Tobramycin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000711	0.000734	CcSEcCtD
Tobramycin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000708	0.000731	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000706	0.000729	CcSEcCtD
Tobramycin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000705	0.000728	CcSEcCtD
Tobramycin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000705	0.000728	CcSEcCtD
Tobramycin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000698	0.00072	CcSEcCtD
Tobramycin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000697	0.000719	CcSEcCtD
Tobramycin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000696	0.000718	CcSEcCtD
Tobramycin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000696	0.000718	CcSEcCtD
Tobramycin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000692	0.000715	CcSEcCtD
Tobramycin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000692	0.000715	CcSEcCtD
Tobramycin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000691	0.000714	CcSEcCtD
Tobramycin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000691	0.000713	CcSEcCtD
Tobramycin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000691	0.000713	CcSEcCtD
Tobramycin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000685	0.000707	CcSEcCtD
Tobramycin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000683	0.000705	CcSEcCtD
Tobramycin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000683	0.000705	CcSEcCtD
Tobramycin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000682	0.000704	CcSEcCtD
Tobramycin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000681	0.000703	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00068	0.000702	CcSEcCtD
Tobramycin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000678	0.0007	CcSEcCtD
Tobramycin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000674	0.000695	CcSEcCtD
Tobramycin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000671	0.000693	CcSEcCtD
Tobramycin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00067	0.000691	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000669	0.000691	CcSEcCtD
Tobramycin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000666	0.000687	CcSEcCtD
Tobramycin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000665	0.000687	CcSEcCtD
Tobramycin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000665	0.000687	CcSEcCtD
Tobramycin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000663	0.000684	CcSEcCtD
Tobramycin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000662	0.000684	CcSEcCtD
Tobramycin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000662	0.000684	CcSEcCtD
Tobramycin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000659	0.00068	CcSEcCtD
Tobramycin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000656	0.000677	CcSEcCtD
Tobramycin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000648	0.000669	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000648	0.000669	CcSEcCtD
Tobramycin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000645	0.000666	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000644	0.000665	CcSEcCtD
Tobramycin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000639	0.00066	CcSEcCtD
Tobramycin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000639	0.000659	CcSEcCtD
Tobramycin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000638	0.000658	CcSEcCtD
Tobramycin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000634	0.000655	CcSEcCtD
Tobramycin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000634	0.000655	CcSEcCtD
Tobramycin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000634	0.000654	CcSEcCtD
Tobramycin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000634	0.000654	CcSEcCtD
Tobramycin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000628	0.000649	CcSEcCtD
Tobramycin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000628	0.000649	CcSEcCtD
Tobramycin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000628	0.000648	CcSEcCtD
Tobramycin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000624	0.000645	CcSEcCtD
Tobramycin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00062	0.00064	CcSEcCtD
Tobramycin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000619	0.000639	CcSEcCtD
Tobramycin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000617	0.000637	CcSEcCtD
Tobramycin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000616	0.000636	CcSEcCtD
Tobramycin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000615	0.000635	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000614	0.000634	CcSEcCtD
Tobramycin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000613	0.000633	CcSEcCtD
Tobramycin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000613	0.000632	CcSEcCtD
Tobramycin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000613	0.000632	CcSEcCtD
Tobramycin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00061	0.00063	CcSEcCtD
Tobramycin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000608	0.000628	CcSEcCtD
Tobramycin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000601	0.000621	CcSEcCtD
Tobramycin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000599	0.000619	CcSEcCtD
Tobramycin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000593	0.000612	CcSEcCtD
Tobramycin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000593	0.000612	CcSEcCtD
Tobramycin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000592	0.000611	CcSEcCtD
Tobramycin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00059	0.000609	CcSEcCtD
Tobramycin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00059	0.000609	CcSEcCtD
Tobramycin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000589	0.000608	CcSEcCtD
Tobramycin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000586	0.000605	CcSEcCtD
Tobramycin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000584	0.000603	CcSEcCtD
Tobramycin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000584	0.000603	CcSEcCtD
Tobramycin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000582	0.000601	CcSEcCtD
Tobramycin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000581	0.0006	CcSEcCtD
Tobramycin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000579	0.000598	CcSEcCtD
Tobramycin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000573	0.000592	CcSEcCtD
Tobramycin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000571	0.000589	CcSEcCtD
Tobramycin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000565	0.000584	CcSEcCtD
Tobramycin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000562	0.000581	CcSEcCtD
Tobramycin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000562	0.000581	CcSEcCtD
Tobramycin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000557	0.000575	CcSEcCtD
Tobramycin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000556	0.000574	CcSEcCtD
Tobramycin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000554	0.000572	CcSEcCtD
Tobramycin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000552	0.00057	CcSEcCtD
Tobramycin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000552	0.00057	CcSEcCtD
Tobramycin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000551	0.000568	CcSEcCtD
Tobramycin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00055	0.000567	CcSEcCtD
Tobramycin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000549	0.000566	CcSEcCtD
Tobramycin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000548	0.000566	CcSEcCtD
Tobramycin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000535	0.000552	CcSEcCtD
Tobramycin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000533	0.00055	CcSEcCtD
Tobramycin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00053	0.000547	CcSEcCtD
Tobramycin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000528	0.000545	CcSEcCtD
Tobramycin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000528	0.000545	CcSEcCtD
Tobramycin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000528	0.000545	CcSEcCtD
Tobramycin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000525	0.000542	CcSEcCtD
Tobramycin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000524	0.000541	CcSEcCtD
Tobramycin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00052	0.000537	CcSEcCtD
Tobramycin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000512	0.000529	CcSEcCtD
Tobramycin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000511	0.000527	CcSEcCtD
Tobramycin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00051	0.000527	CcSEcCtD
Tobramycin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000503	0.00052	CcSEcCtD
Tobramycin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000498	0.000514	CcSEcCtD
Tobramycin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000493	0.000509	CcSEcCtD
Tobramycin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000493	0.000509	CcSEcCtD
Tobramycin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000489	0.000504	CcSEcCtD
Tobramycin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000488	0.000504	CcSEcCtD
Tobramycin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000487	0.000503	CcSEcCtD
Tobramycin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000485	0.000501	CcSEcCtD
Tobramycin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000474	0.00049	CcSEcCtD
Tobramycin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000471	0.000486	CcSEcCtD
Tobramycin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00047	0.000486	CcSEcCtD
Tobramycin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00047	0.000485	CcSEcCtD
Tobramycin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000467	0.000482	CcSEcCtD
Tobramycin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00046	0.000475	CcSEcCtD
Tobramycin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000452	0.000467	CcSEcCtD
Tobramycin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000449	0.000463	CcSEcCtD
Tobramycin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000448	0.000463	CcSEcCtD
Tobramycin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000446	0.00046	CcSEcCtD
Tobramycin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000443	0.000457	CcSEcCtD
Tobramycin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000423	0.000436	CcSEcCtD
